Newsletter - November I - 2011

Residue Plex™ launch at RAFA 2011

RnAssays attended RAFA 2011 to share the news of Residue Plex™ with a global audience. Our latest product can identify and report the presence of multiple antibacterial residue families simultaneously from one sample. We spoke with interested parties from over 20 countries about the benefits of our flow cytometry affinity assays.

The strength of Residue Plex screening technology is that it complements expensive methods, such as hyphenated tandem mass spectrometry (MS), which have limited throughput. Residue Plex lets you filter out compliant (negative) samples very cost-effectively.

   

Suspect samples can then be confirmed by the MS method. This two-step analysis makes the diagnostic process much cheaper and more efficient.

Residue Plex has recently produced some significant validation data. If you would like to receive a copy of this, please email c.greenhalgh@rnassays.com